Step-down strategy of spacing TNF-blocker injections for established rheumatoid arthritis in remission: results of the multicentre non-inferiority randomised open-label controlled trial(STRASS: Spacing of TNF-blocker injections in Rheumatoid ArthritiS Study)-Reference-Cited by-同舟云学术

Step-down strategy of spacing TNF-blocker injections for established rheumatoid arthritis in remission: results of the multicentre non-inferiority randomised open-label controlled trial(STRASS: Spacing of TNF-blocker injections in Rheumatoid ArthritiS Study)

Published:2015-06-23 Issue:1 Volume:75 Page:59-67
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Ann Rheum Dis

Author:

Fautrel Bruno,Pham Thao,Alfaiate Toni,Gandjbakhch Frédérique,Foltz Violaine,Morel Jacques,Dernis Emmanuelle,Gaudin Philippe,Brocq Olivier,Solau-Gervais Elisabeth,Berthelot Jean-Marie,Balblanc Jean-Charles,Mariette Xavier,Tubach Florence

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Reference47 articles.

1. Can remission be maintained with or without further drug therapy in rheumatoid arthritis?;Saleem;Clin Exp Rheumatol,2006

2. EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT);Combe;Ann Rheum Dis,2007

3. Treating rheumatoid arthritis to target: recommendations of an international task force;Smolen;Ann Rheum Dis,2010

4. RA in 2011: advances in diagnosis, treatment and definition of remission;Burmester;Nat Rev Rheumatol,2012

5. Efficacy of conventional synthetic disease-modifying antirheumatic drugs, glucocorticoids and tofacitinib: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis;Gaujoux-Viala;Ann Rheum Dis,2014

Cited by 124 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimizing withdrawal strategies for anti-TNF-α therapies in rheumatoid arthritis;Expert Opinion on Biological Therapy;2024-07-25

2. What are the benefits of therapeutic drug monitoring in the optimization of adalimumab therapy? a systematic review and meta-analysis up to 2022;Frontiers in Pharmacology;2024-07-08

3. Coût et analyse médico-économique de la polyarthrite rhumatoïde;Revue du Rhumatisme;2024-05

4. Predicting Flare in Patients With Rheumatoid Arthritis in Biologic Induced Remission, on Tapering, and on Stable Therapy;ACR Open Rheumatology;2024-02-27

5. Towards the Lowest Efficacious Dose: Results From a Multicenter Noninferiority Randomized Open‐Label Controlled Trial Assessing Tocilizumab or Abatacept Injection Spacing in Rheumatoid Arthritis in Remission;Arthritis & Rheumatology;2024-01-25